Sequence information
DRAVP ID DRAVPc005
Name Sifuvirtide
Sequence
Molecular Formula C201H307N59O71
Condition/Disease HIV Infections
Group Phase Ⅲ clinical trial
Type Peptide
Description Sifuvirtide is a linear 36-amino acid residues anti-HIV peptide, which designed based on the 3D structure of the HIV-1 gp41 fusogenic core conformation.
Active sequence/Structure
External Links
DrugBank Accession Number Not Available
Pubchem ID 49769437
CHEMBL ID Not Available
UNII Not Available
CAS Not Available
ClinicalTrails Information
| NCT Number | Study Title | Condition/Disease | Status | Phase | Sponsor |
|---|---|---|---|---|---|
| ChiCTR-TRC-08000238 | Efficacy, safety, and pharmacokinetics study of Sifuvirtide for Injection in combination with HAART therapy in HIV infected subjects | Human Immunodeficiency Virus (HIV) Infections | Unknow | Phase II | Ethic committee of Beijing Youan Hospital |
| ChiCTR-TRC-08000211 | Safety and Pharmacokinetics Study of Multiple Dose Administration of Sifuvirtide in HIV-infected volunteers (FS0103) | Human Immunodeficiency Virus (HIV) Infections | Unknow | Phase II | Ethic committee of Beijing Youan Hospital |
